PatientSafe INDIA is the annual event organized as a part of the industry initiative on tackling Drug Counterfeiting. The initiative is being planned by OPPIwith the support of affiliate associations like IDMA, IPA, IMA and AIOCD and is being facilitated by SynCore Consulting.
The aim of the initiative is to ensure patient safety by addressing the challenge of drug counterfeiting through programs such as trade meets, round tables and conferences.
At the 6th FICCI – HADSA International Nutraceutical Conference (held in Mumbai on 6th May 2015) with the Theme “Make in India – Nutraceutical Opportunities”, SynCore Consulting and FICCI – HADSA came together to understand the requirements of the Indian manufacturing sector to become a recognized global supplier of nutraceuticals.
A Knowledge Report was launched entitled "Make in India - Nutraceuticals Opportunities" published by SynCore Consulting (Knowledge Partner) and FICCI-HADSA
SynCore Consulting now is nominated as one of '25 Most Promising Business Consultant Companies in India' by Consultants Review Magazine. You can read a complete interview of Mr. Javin Bhinde, Executive Director - SynCore Consulting Group in the December 2014 issue of Consultants Review Magazine.